Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_assertion type Assertion NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_head.
- NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_assertion description "[HECV(mat2 exp) cells inoculated into CD-1 athymic mice along with either PC-3 prostate cancer cells or MDA-MB-231 breast cancer cells showed a dramatic decrease in tumour development and growth in the prostate tumours (p < 0.01) and a lesser, non-significant, decrease in the breast tumours (p = 0.08).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_provenance.
- NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_assertion evidence source_evidence_literature NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_provenance.
- NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_assertion SIO_000772 23238872 NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_provenance.
- NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_assertion wasDerivedFrom befree-20140225 NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_provenance.
- NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_assertion wasGeneratedBy ECO_0000203 NP869767.RApKoP7wDqdu2r7G2-anAbeoGjtp7Yew6Yvj0k9-lA5bs130_provenance.